Increase in C-reactive protein plasma levels during diabetes in infants and young adults;Augmentation de la concentration plasmatique de la protéine C-réactive dans le diabète de l'enfant et de l'adulte jeune

Presse Medicale

Volumn 34, Issue 2 I, 2005, Pages 89-93

  Coulon, J ^a   Willems, D ^b   Dorchy, H ^a  

^a HOP UNIV DES ENFANTS REINE FABIOLA   (Belgium)

^b BRUGMANN UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE MARKER; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN DETERMINATION; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

EID: 13244277936     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(05)88234-x     Document Type: Article

References (20)

1. Pirart J. Diabète et complications dégéné ratives. Présentation d'une étude prospective sur 4400 cas observés entre 1947 et 1975. Diabete Metab 1997; 3: 97-107, 173-82, 245-46.
2. The Diabetes Control and Complications Trial Research Group. Effect of intensive treatment of diabetes on the development and the progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 29: 977-86.
3. Verougstraete C, Libert J, Dorchy H. Discordant diabetic retinopathy in homozygous twins: the importance of good metabolic control. J Pediatr 1999; 134: 658.
4. Liuzzo G, Biasucci LM, Gallimore JR, Grillo RL, Rebuzzi Ag, Pepys MB et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
5. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-9.
6. Ridker PM, Kennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43.
7. Moran MR, Guerrero-Romero F. Increased levels of C-reactive protein in noncontrolled type Il diabetic subjects. J Diabetes Complications 1999; 13: 211-15.
8. Mojminiyi OA, Abdella N, Moussa MA, Akanji AO, Al Mohammedi H, Zaki M. Association of C-reactive protein with coronary heart disease risk factors in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2002; 58: 37-44.
9. Guerrero-Romero F, Rodriguez-Moran M. Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects. Diabetes Metab 2003; 29: 65-71.
10. Schalkwijk CG, Poland DC, van Dijk W, Kok A, Emeis JJ, Drager AM. Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation. Diabetologia 1999; 42: 351-57.
11. Okano RM, Yamasaki Y, Katakami N, Ohtoshi K, Gorogawa S, Kuroda A et al. Elevated C-reactive protein associates with early-stage carotid atherosclerosis in young subjects with type 1 diabetes. Diabetes Care 2002; 25: 1432-38.
12. Dorchy H. Insulin regimens and injection adjustments in diabetic children, adolescents and young adults: personal experience. Diabetes Metab 2000; 26: 500-7.
13. Dorchy H, Roggemans MP, Willems D. Glycated hemoglobin and related factors in diabetic children and adolescents under 18 years of age: a Belgian experience. Diabetes Care 1997; 20: 2-6.
14. Dorchy H. Dépistage des complications subcliniques chez les jeunes diabétiques: l'expérience bruxelloise. Ann Pediatr 1998; 45: 585-606.
15. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-65.
16. Romano M, Pomilio M, Vigneri S, Falco A, Chiesa PL, Chiarelli F et al. Endothelial perturbation in children and adolescents with type 1 diabetes. Diabetes Care 2001; 24: 1674-8.
17. Piéroni L, Bastard JP, Piton A, Khalil L, Hainque B, Jardel C. Interpretation of circulating C-reactive protein levels in adults: Body Mass Index and gender are a must. Diabetes Meta 2003; 29: 133-8.
18. Hutchinson WL, Köenig W, Fröhlich M, Sund M, Löwe GD, Pepys MB. Immunoradiometric assay of circulating C-reactive protein: age-related values in the general adult population. Clin Chem 2000; 46: 934-8.
19. Ford ES, Giles WH, Myers GL, Rifai N, Ridker PM, Mannino DM. C-reactive Protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey 1999-2000. Clin Chem 2003; 49: 1353-7.
20. Herberth B, Siest G, Henny J. High sensitivity C-reactive protein (CRP) reference intervals in the elderly. Clin Chem Lab Med 2001; 11: 1169-70.